• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[甲型肝炎减毒活疫苗H2株在普通狨猴体内的实验性传代]

[Experimental in vivo passage of H2 strain of live attenuated vaccine of hepatitis A in common marmosets].

作者信息

Huang X, Lian Y, Wang Q

机构信息

Institute of Medical Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Kunming.

出版信息

Zhonghua Yu Fang Yi Xue Za Zhi. 1997 Sep;31(5):260-2.

PMID:9812599
Abstract

Common marmosets with negative serum antibodies against hepatitis A virus (anti-HAV) and normal liver functions were used for the tests of passage of H2 vaccine strain of HAV to explore its residual virulence after attenuation and possibility of its reversion. Common marmosets were inoculated with attenuated live vaccine, and fecal suspension and/or proliferative liquid in tissue culture of the progeny of vaccine HAV excreted from their feces were passaged in common marmosets. Result of three serial passages in vivo indicated that there was no significant difference in serum anti-HAV titer, and no or low-level changes in activities of liver enzymes, no pathological changes in liver tissues observed, and detectable but minimal HAV was shed in stool of the all animals.

摘要

选用血清抗甲型肝炎病毒(抗-HAV)阴性且肝功能正常的普通狨猴进行甲型肝炎病毒H2疫苗株传代试验,以探索其减毒后的残余毒力及返祖可能性。给普通狨猴接种减毒活疫苗,并将从其粪便中排出的疫苗甲型肝炎病毒子代的粪便悬液和/或组织培养增殖液在普通狨猴体内传代。体内连续传代3次的结果表明,血清抗-HAV滴度无显著差异,肝酶活性无变化或仅有低水平变化,未观察到肝组织病理变化,所有动物粪便中均可检测到但含量极低的甲型肝炎病毒。

相似文献

1
[Experimental in vivo passage of H2 strain of live attenuated vaccine of hepatitis A in common marmosets].[甲型肝炎减毒活疫苗H2株在普通狨猴体内的实验性传代]
Zhonghua Yu Fang Yi Xue Za Zhi. 1997 Sep;31(5):260-2.
2
[Horizontal transmission of live attenuated hepatitis A vaccine virus].[甲型肝炎减毒活疫苗病毒的水平传播]
Zhonghua Yi Xue Za Zhi. 2001 Apr 25;81(8):465-7.
3
Safety and immunogenicity of live attenuated hepatitis A virus vaccine (H2 strain) in humans.甲型肝炎减毒活疫苗(H2株)在人体中的安全性和免疫原性。
Chin Med J (Engl). 1993 Aug;106(8):604-7.
4
[Observation of live, attenuated hepatitis A vaccines in humans].[人用甲型肝炎减毒活疫苗的观察]
Zhonghua Yu Fang Yi Xue Za Zhi. 1993 Mar;27(2):65-8.
5
Live attenuated vaccine for hepatitis A.甲型肝炎减毒活疫苗。
Dev Biol Stand. 1983;54:429-32.
6
Progress toward a live attenuated human hepatitis A virus vaccine.减毒活甲型肝炎病毒疫苗的研究进展。
Dev Biol Stand. 1983;54:433-40.
7
Further evaluation of a live hepatitis A vaccine in marmosets.狨猴中甲型肝炎活疫苗的进一步评估。
J Med Virol. 1991 Aug;34(4):227-31. doi: 10.1002/jmv.1890340406.
8
[Immunological effects of live attenuated hepatitis A vaccine].[甲型肝炎减毒活疫苗的免疫效果]
Zhonghua Yi Xue Za Zhi. 1992 Oct;72(10):581-3, 638.
9
Development of live attenuated hepatitis A vaccine (H2-strain).减毒活甲型肝炎疫苗(H2株)的研发。
Chin Med J (Engl). 1992 Mar;105(3):189-93.
10
Studies of prototype live hepatitis A virus vaccines in primate models.甲型肝炎病毒原型活疫苗在灵长类动物模型中的研究。
J Infect Dis. 1988 Feb;157(2):338-45. doi: 10.1093/infdis/157.2.338.

引用本文的文献

1
The infectivity and pathogenicity of hepatitis A virus live-attenuated vaccine strain H2 in type I interferon receptor-deficient mice.甲型肝炎病毒活疫苗株 H2 在 I 型干扰素受体缺陷型小鼠中的感染性和致病性。
Virol Sin. 2022 Oct;37(5):740-745. doi: 10.1016/j.virs.2022.07.009. Epub 2022 Jul 19.
2
Live attenuated hepatitis A vaccines developed in China.中国研发的甲型肝炎减毒活疫苗。
Hum Vaccin Immunother. 2014;10(3):659-66. doi: 10.4161/hv.27124. Epub 2013 Nov 26.